Hidrocortisona Klonal

Quick links

Choose a section

Quick links to important sections

Advertisements
Advertisements

Overview of Hidrocortisona Klonal

Quick Facts

Property Description
Active ingredient Hydrocortisone (Cortisol)
Form Tablets, Injectable, Cream, Ointment, Lotion
Pharmacological class Glucocorticoid, Corticosteroid
Common purpose Mitigating inflammation and immune response
Origin Synthetic equivalent of a natural hormone

What Type of Medicine is Hidrocortisona Klonal?

Hidrocortisona Klonal is a pharmaceutical preparation whose active ingredient, Hydrocortisone, is classified as a potent Glucocorticoid belonging to the broader Corticosteroid pharmacological class. This substance is the synthetic, therapeutic equivalent of Cortisol, the primary adrenocortical steroid naturally produced in the human body. This class is clinically recognized for its essential role in treating various inflammatory and immune-mediated responses.

The medication's identity is founded upon the Hydrocortisone molecule, which, in the context of the Hidrocortisona Klonal brand, is typically distributed with a Prescription-only (Rx) status in regulated markets, underscoring its therapeutic potency and requirement for medical supervision. Hydrocortisone is utilized in the systemic context as a short-acting steroid, maintaining a close structural and functional similarity to the endogenous hormone.


Composition and Available Forms

The medication is a single-ingredient product, containing either the Hydrocortisone base compound or a specialized, highly soluble derivative, such as Hydrocortisone Sodium Succinate. The sodium succinate ester form is typically reserved for rapid, Injectable (parenteral) administration when immediate systemic relief is medically necessary.

The formulation dictates the required Route of administration and is available in multiple Dosage form(s). Systemic delivery is achieved through Comprimidos (tablets), while Topical forms, including Cream or Ointment, are utilized for localized application. This diversity in forms is tailored to address both widespread internal issues and specific external skin manifestations.


General Therapeutic Function

The general function of Hydrocortisone is to relieve swelling, intense itching, and redness by delivering a strong anti-inflammatory action and immunosuppressive effect. This class of drug is recognized for its effectiveness in reducing the physical signs of acute inflammation. The primary role of the drug is to temper the body’s inflammatory pathways, providing general relief from severe inflammatory and allergic manifestations.

Advertisements

What side effects are possible with Hidrocortisona Klonal?

Possible Side Effects and Safety Information

This section outlines the officially documented adverse reactions and safety restrictions for Hidrocortisona Klonal, strictly as categorized and reported by government regulatory authorities.

Adverse Reaction Scope

The safety profile is structured to categorize unwanted effects by the body systems they affect (System-Organ Class, or SOC). Documented adverse reactions span multiple systems, including the nervous system (e.g., headache), the gastrointestinal system (e.g., nausea), and the skin (e.g., acne). Frequency classifications, when determined, are used to indicate the estimated incidence of these effects.

Clinically Significant and Serious Adverse Reactions

Certain reactions are officially designated as Serious Adverse Reactions due to their severity or clinical consequence. These documented high-risk events include, but are not limited to, hallucinations, seizures, severe stomach pain, and signs of infection.

Safety Restrictions and Population-Specific Risks

Official regulatory documents define Contraindications, which are conditions where the medicine must not be used due to a high risk; this includes patients with systemic fungal infections. Additionally, specific routes of administration, such as intrathecal use, are restricted.

Safety notes specify risks related to the duration and dose of exposure. Long-term, high-dose use is officially associated with risks like osteoporosis and the potential for adrenal insufficiency if the medicine is abruptly discontinued. Population-specific considerations are documented for pediatric patients, noting potential effects on growth and development.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Hydrocortisone (the active substance in Hidrocortisona Klonal) overdose, while generally considered less common to result in severe, acute, life-threatening symptoms from a single large exposure, requires immediate attention. Corticosteroid overdose most often leads to disturbances in the body's fluid and electrolyte balance, which may be mild but can occasionally escalate to more serious complications, particularly with excessive long-term use.

Overdose Symptoms and Clinical Features

The clinical manifestations associated with corticosteroid overdose may include increased blood pressure, disturbances in heart rhythm, or altered mental status such as agitation. With prolonged excessive exposure, a patient may develop symptoms resembling Cushing's syndrome, such as significant weight gain, rounding of the face (moon face), and fluid retention. Additionally, neurological effects such as convulsions, depression, or severe headache have been documented in association with high-dose or excessive corticosteroid exposure.

Required Emergency Actions

If you suspect an overdose, you should seek immediate medical assistance. Contact your local emergency services or a Poison Control Center right away, even if no symptoms are immediately apparent. It is vital to provide the healthcare professionals with details regarding the amount of medication taken, the time of exposure, and the person’s current condition. Treatment for overdose is typically supportive, focusing on managing symptoms and restoring the body's normal fluid and electrolyte balance. The prognosis is generally favorable unless severe, life-threatening symptoms, such as significant cardiac disturbances, are present. Do not attempt to self-treat the overdose.

Advertisements

Therapeutic Uses of Hidrocortisona Klonal

Hydrocortisone is a medication that may be part of symptomatic management in two primary therapeutic areas. It is commonly used to help with hormone replacement in patients with adrenocortical insufficiency, addressing symptoms related to systemic imbalance.

Its second use is relevant in contexts involving heightened systemic burden. Hydrocortisone is applied in addressing conditions involving inflammatory or irritative states. This is relevant for easing symptoms that interfere with daily comfort in clinical scenarios such as certain rheumatic disorders, severe allergic states, specific dermatologic diseases, and various gastrointestinal diseases.

This approach contributes to improved comfort during periods of heightened symptoms. It supports the patient during difficult episodes by easing distress. “The medication supports general well-being during symptomatic phases,” as it may assist with maintaining functional stability when symptoms interfere with routine activities. It is commonly used across conditions presenting with acute episodes.

Quick Fact: Relief for Symptoms that Create Noticeable Physiological Strain

Advertisements

Eligibility and Restrictions for Use

Eligibility for Use: Official Regulatory Information

Hidrocortisona Klonal (Systemic Hydrocortisone) is allowed for use in patients with Adrenocortical Insufficiency and those requiring relief for certain inflammatory or immune-mediated disorders, as specified in the medicine's label.

Absolute Contraindications

Use is strictly prohibited in patients with the following conditions, according to regulatory documents:

  • Systemic Fungal Infections
  • Known Hypersensitivity to Hydrocortisone or any product component
  • Patients receiving Live or Live Attenuated Vaccines (when the medicine is used at immunosuppressive doses)
  • Neonates or Premature Infants (for injectable formulations containing benzyl alcohol)

Restricted and Conditional Use

Use requires close monitoring or specific caution in patients with comorbidities such as Hypertension, Diabetes Mellitus, Osteoporosis, Glaucoma, Active or Latent Tuberculosis, and Peptic Ulcer Disease. These conditions necessitate caution as the medicine may exacerbate them.

Age and Reproductive Eligibility

Population Official Regulatory Status
Pediatric Use Generally approved; however, chronic use requires monitoring for potential suppression of growth and development.
Pregnancy Use is classified as Category C (parenteral) or Category A (oral/rectal forms, varying by region). Permitted only if the potential benefit justifies the potential risk to the fetus.
Lactation Generally compatible for replacement doses; infants of mothers taking prolonged high doses should be monitored for adrenal suppression.

This eligibility profile defines clear exclusion criteria (contraindications) and specific restrictions for use in vulnerable or high-risk patient populations.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Hydrocortisone (Hidrocortisona Klonal) interacts with several medicinal products and substances, primarily by affecting its concentration in the body or by increasing the risk of specific adverse effects when co-administered. This information is based on official regulatory labeling.

Exposure-Modifying Interactions (Pharmacokinetic)

Type of Interacting Agent Effect on Hydrocortisone Exposure
CYP3A4 Inhibitors (e.g., Ketoconazole, Ritonavir, Grapefruit Juice) Increase blood levels (decreased metabolism)
CYP3A4 Inducers (e.g., Rifampin, Phenytoin, Phenobarbital) Decrease blood levels (increased metabolism)

Pharmacodynamic and Combination Restrictions

Interacting Substance/Class Resulting Constraint or Risk
Mifepristone Use is contraindicated (must not be combined)
Potassium-Depleting Diuretics Increased risk of hypokalemia (additive effect)
Antidiabetic Agents (e.g., Insulin) Reduced effectiveness of the antidiabetic (hydrocortisone increases blood glucose)
Anticoagulants (e.g., Warfarin) Effects may be altered, requiring close monitoring
Live Vaccines (at immunosuppressive doses) Contraindicated due to risk of disseminated infection

These interactions necessitate careful monitoring and, in many cases, adjustment of the dose for hydrocortisone or the co-administered drug to maintain therapeutic effectiveness and minimize risk. Patients should inform their healthcare provider of all concurrent medications, supplements, and dietary choices.

Advertisements

Mechanism of Action

How Hidrocortisona Klonal Works

Engagement with Intracellular Receptors

Hidrocortisona Klonal acts within domains involving receptor-mediated signaling by binding to and activating the cytosolic Glucocorticoid Receptor (GR). This initiates or suppresses signaling sequences that lead to downstream effects through the regulation of gene expression.


Modulation of Inflammatory Pathways

The drug engages mechanisms that modulate signaling associated with physiological inflammatory responses primarily through transrepression. It affects systems where specific inflammatory mediators dominate, resulting in specific physiological modulations. It acts by attenuating the synthesis and release of specific inflammatory mediators through suppressing the genes for pro-inflammatory proteins (e.g., cytokines and chemokines).


Influence on Immune Cell Function

Hidrocortisona Klonal is relevant in cascades where multiple layers of pathway activation occur, altering pathway activity that may escalate under certain conditions. It modifies early molecular steps that shape systemic physiological outcomes by influencing the trafficking and function of various immune and inflammatory cells to alter systemic physiological regulation.

Advertisements

Dosage and Administration Information

How to Use Hidrocortisona Klonal: Official Administration and Dosing

The usage of Hidrocortisona Klonal (Hydrocortisone) is dictated by its intended effect and its approved pharmaceutical form, following established guidelines to ensure proper administration. This section outlines the official instructions for use.


Approved Routes and Forms

Hydrocortisone is approved for several distinct administration routes, aligning with the available dosage forms:

  • Oral (Systemic): Administered as tablets (5 mg, 10 mg, or 20 mg) or oral granules. This route is typically used for long-term conditions like replacement therapy.
  • Parenteral (Systemic): Administered as the specialized derivative, Hydrocortisone Sodium Succinate (sterile powder), via Intravenous (IV) Injection, IV Infusion, or Intramuscular (IM) Injection. This method is reserved for acute, severe needs.

Standard Dosing Regimens and Frequency

Dosing is highly individualized and must use the lowest effective dose. Examples of approved regimens include:

Therapeutic Context Standard Dosing (Official Range) Frequency
Adrenocortical Replacement (Oral) Typically 15 mg to 25 mg per day Divided into two to four doses daily.
Acute Severe Crisis (Parenteral) Initial dose of 100 mg to 500 mg May be repeated at intervals of 2, 4, or 6 hours.

Administration Requirements

  • Oral Intake: Tablets may be taken with or after food to aid intake.
  • Parenteral Preparation: The sterile powder must first be reconstituted with a compatible diluent before it can be injected or prepared for IV infusion.
  • Pediatric Dosing: For replacement therapy, the dosage is calculated based on Body Surface Area (BSA) (e.g., 8 to 10 mg/ m^2/ day), administered in divided doses.

Use Over Time and Adjustments

Long-term use requires specific management protocols. High-dose parenteral therapy is typically limited to 48 to 72 hours. Following prolonged use, the drug must be withdrawn gradually (tapering) rather than abruptly. The dose may also need to be temporarily increased during periods of physical stress or illness.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Hidrocortisona Klonal

This summary provides an overview of the types of studies conducted, the outcomes measured, and where evidence limitations exist.


Evidence for Hormone Replacement in Adrenocortical Insufficiency

Research for this use is foundational, relying on studies that explore how the body processes the medication and how it is evaluated for its role as a replacement hormone. Researchers have utilized pharmacokinetic/pharmacodynamic (PK/PD) studies to analyze the concentration of hydrocortisone in the blood over a 24-hour period. These studies aim to explore the physiological pattern of replacement to describe how closely the pattern of the drug's concentration matches the natural diurnal rhythm of the body's cortisol production.

Long-term observational studies and patient registries described the tracking of clinical symptoms, such as weakness and fatigue, and what studies monitored regarding physiological stability. This use is documented in regulatory and clinical guidelines and supported by decades of observational experience. Research explores how to optimize the use and formulation of the drug. Few large, modern Randomized Controlled Trials (RCTs) against placebo exist to assess replacement, which is common where ethical concerns limit the ability to withhold a life-sustaining hormone.


Evidence for Adjunctive Use in Septic Shock

The evidence base for the use of hydrocortisone in acute, severe inflammatory states like septic shock is built upon multiple large-scale Randomized Controlled Trials (RCTs) and systematic reviews. These studies included critically ill adults who required support to maintain their blood pressure.

Research explored key short-term clinical outcomes such as all-cause mortality at defined intervals, the time to circulatory shock reversal, and how long patients required vasopressor drugs to support blood pressure. Findings were mixed across some of the largest available trials regarding the ultimate 90-day survival outcome. However, several trials described patterns related to the duration of vasopressor support in patients receiving hydrocortisone compared to those who received a placebo. Research remains ongoing to clarify which specific patient subgroups may derive a clinically meaningful outcome from this adjunctive treatment.


What Research Remains Uncertain or Inconsistent

The available evidence highlights several areas where certainty remains low or where additional research is needed:

  • Long-Term Neurodevelopment: For the treatment in premature infants, the outcomes on neurodevelopmental profile beyond the initial two-year follow-up period are not fully established, and more data are still emerging.
  • Subgroup Analysis: Data for certain specific groups, such as older adults with multiple comorbidities in critical care settings, remain limited, and the general findings describe group patterns, not personal outcomes.
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Hidrocortisona Klonal (FAQ)


Q: Why is Hidrocortisona Klonal used for skin problems?

Official regulatory documents indicate that topical hydrocortisone products are used to relieve the symptoms of certain corticosteroid-responsive skin conditions. Its main purpose is to reduce the inflammation and itching (pruritic manifestations) that occur with these skin issues.


Q: What is the difference between Hidrocortisona Klonal and other hydrocortisone creams?

Hydrocortisone is the name of the active pharmaceutical ingredient. The differences between this brand and other hydrocortisone creams usually relate to the inactive ingredients (excipients) used in the formulation, or whether the product is a cream, ointment, or lotion. These variations are all defined within official regulatory approvals.


Q: Is it true that Hidrocortisona Klonal can thin the skin over time?

Official safety information documents thinning of the skin (atrophy) as a documented adverse effect associated with the continuous, prolonged use of topical corticosteroids. This risk is managed by official guidance which typically restricts use to the shortest necessary duration.


Q: Does Hidrocortisona Klonal cause weight gain or other systemic effects?

When applied topically, a sufficient amount of the medication can be absorbed into the body (systemic absorption), especially when used improperly. Official warnings note that this absorption can potentially lead to serious systemic effects, including manifestations associated with Cushing's syndrome, which may involve symptoms like weight gain.


Q: What are the most commonly reported side effects of Hidrocortisona Klonal?

The most common reactions are typically limited to the application site, such as mild burning, stinging, itching, or irritation. These effects are often described in official safety information as temporary.


Q: What if I accidentally use too much Hidrocortisona Klonal?

Regulatory documents caution that applying excessive amounts of the product can lead to greater absorption into the body, which increases the risk of serious side effects. Official documents note that overuse or prolonged use may increase the need for medical supervision.


Q: Does using a large amount of Hidrocortisona Klonal increase the risk of side effects?

Yes, official guidance advises that applying the medicine over large surface areas or using large amounts over a long period increases systemic absorption. This heightened absorption directly increases the overall risk of experiencing adverse effects.


Q: Why do official documents warn about using Hidrocortisona Klonal with certain dressings?

Official information warns that covering the treated area with occlusive dressings (airtight coverings) can significantly boost the amount of the drug absorbed through the skin. This effect increases the possibility of systemic side effects.


Q: What should I do if my symptoms get worse while using Hidrocortisona Klonal?

Regulatory guidance specifies that if the treated condition worsens, irritation develops, or there is no improvement within a designated short timeframe (often 7 days), the drug must be discontinued and a healthcare provider should be consulted.


Q: Does using other skin products at the same time affect Hidrocortisona Klonal?

Official precautions advise against using cosmetics or other skin care products on the treated areas unless specifically recommended by a healthcare provider. This is because other products could potentially alter how the medicine is absorbed or increase the risk of skin irritation.


Q: Is Hidrocortisona Klonal absorbed into the bloodstream?

Yes, regulatory documents confirm that when applied to the skin, hydrocortisone can be absorbed into the bloodstream (systemic circulation). The amount absorbed depends on factors like the condition of the skin barrier and the area being treated.


Q: What is the usual recommended duration of treatment with Hidrocortisona Klonal?

For self-directed use of common, low-strength topical forms, official regulatory advice limits use to no more than 7 consecutive days without specific medical direction. Use beyond this timeframe requires monitoring.


Q: How quickly does Hidrocortisona Klonal usually start working?

The anti-inflammatory effects of the medicine often begin shortly after application. Observable relief from symptoms like itching and redness typically starts within a short timeframe, though the full benefit may take longer.


Q: What happens if I stop using Hidrocortisona Klonal suddenly?

Regulatory documents indicate that abrupt discontinuation after prolonged or continuous use may result in a condition known as 'topical steroid withdrawal.' This reaction can cause a worsening of the original skin condition along with intense redness, burning, and peeling.


Q: How long can a person safely use Hidrocortisona Klonal continuously?

Regulatory guidance limits continuous topical use without medical supervision to typically 7 days. Long-term use is associated with a greater risk of adverse local and systemic effects and is only permitted under strict medical supervision.


Q: Is Hidrocortisona Klonal safe for children?

The drug is approved for use in children, but official warnings state that pediatric patients are more susceptible to systemic toxicity and potential effects on growth and development due to greater skin absorption. Therefore, chronic or extensive use should be managed under medical supervision.


Q: What type of skin conditions is Hidrocortisona Klonal generally not recommended for?

It is generally not recommended for skin conditions where an active infection is present, such as fungal, bacterial, or viral skin infections. Official guidance also cautions against its use for certain issues like rosacea, acne, or skin ulcers, as it can worsen these problems.


Q: Does Hidrocortisona Klonal affect blood sugar levels in people with diabetes?

Official regulatory precautions state that systemic absorption of hydrocortisone can potentially cause elevated blood sugar levels (hyperglycemia). For this reason, individuals with diabetes are identified as a population for whom caution and close monitoring are advised during use.


Q: Is Hidrocortisona Klonal the same as just 'hydrocortisone'?

Hydrocortisone is the active ingredient, which is classified as a potent glucocorticoid. 'Hidrocortisona Klonal' is the specific brand or trade name under which this active ingredient is manufactured and marketed according to its regulatory approval.


Q: Are there different strengths of Hidrocortisona Klonal available?

Yes, hydrocortisone is available in various strengths depending on the formulation and indication. Common topical strengths include 0.5% and 1.0% for milder issues, with other higher-strength options potentially available by prescription.


Q: Can Hidrocortisona Klonal be used for insect bites?

Yes, official indications generally cover the relief of inflammation and itching associated with conditions such as insect bites and stings, as these symptoms are often responsive to topical corticosteroids.


Q: Is there a risk of allergy to the inactive ingredients in Hidrocortisona Klonal?

Yes, regulatory documents list a known hypersensitivity or allergy to any component of the preparation—including inactive ingredients (excipients)—as a contraindication (a condition that strictly prohibits use).


Q: What kind of studies have been done on the safety profile of Hidrocortisona Klonal?

The safety profile is established through a combination of clinical trials, post-marketing surveillance (pharmacovigilance), and studies focusing on the drug's absorption into the body (pharmacokinetics). These studies help regulatory bodies understand and document potential risks.


Q: Why is it important to wash hands after applying Hidrocortisona Klonal?

Administration instructions commonly advise washing hands thoroughly after applying the medication. This practice is recommended to prevent the accidental transfer of the drug to sensitive body areas, such as the eyes, or to other people.


Q: Can Hidrocortisona Klonal be used on broken skin or open wounds?

Official guidance often cautions against applying the medicine to open wounds, broken, or severely injured skin. Doing so can increase the risk of infection and may also increase the amount of medicine absorbed into the body.


Q: Is Hidrocortisona Klonal known to cause pigmentation changes?

Yes, official safety documentation notes that changes in skin color, including the lightening or darkening of the treated skin area, are possible adverse effects of using topical corticosteroids.


Q: What happens if I forget to apply Hidrocortisona Klonal at the scheduled time?

Official instructions generally state that if a dose is missed, it should be applied as soon as the user remembers, unless it is very close to the time for the next scheduled dose. In that case, the missed dose should be skipped, and the regular schedule resumed. Official instructions advise against taking two applications to compensate for a forgotten one.


Q: Does alcohol consumption affect the use of Hidrocortisona Klonal?

While direct interactions are not typically listed for topical use, official regulatory sources recommend informing a healthcare professional about the use of all substances, including alcohol and dietary choices, during treatment.


Q: Why might a doctor prescribe Hidrocortisona Klonal instead of another topical steroid?

Hydrocortisone is generally classified as a low-potency (mild) corticosteroid. A doctor may prescribe it when treating less severe skin conditions, or when application to sensitive areas (like the face) requires a medication with a lower risk of side effects.


Q: Is it a common practice to use Hidrocortisona Klonal for a short period only?

Yes, official regulatory guidance consistently emphasizes that the medication should be used for the shortest possible duration required to treat the condition. This practice is to minimize the risk of developing adverse local or systemic effects.


Q: Are there specific instructions for disposing of unused Hidrocortisona Klonal?

Official disposal guidance directs users to dispose of all unused or expired medicine according to local pharmaceutical waste regulations. It should not be thrown into the regular household trash or flushed down the toilet.


Q: Do studies suggest any difference in effect based on the skin area applied?

Regulatory documents imply differences in effect and risk based on the application site. They caution that absorption is greater in areas with thin skin, such as the face or skin folds, which increases the likelihood of side effects.


Q: How does Hidrocortisona Klonal compare to a systemic steroid medication?

Hidrocortisona Klonal in topical forms is designed to have a local effect on the skin to treat external conditions. Systemic steroid medications (tablets or injections) are designed to be absorbed into the entire body to treat internal, widespread conditions.


Q: What does the research say about the effectiveness of Hidrocortisona Klonal for seborrheic dermatitis?

Systematic reviews and studies acknowledge that short courses of topical corticosteroids, including hydrocortisone, are considered effective in reducing common symptoms of seborrheic dermatitis, such as scaling, redness, and itching.


Q: Are there known interactions between Hidrocortisona Klonal and herbal supplements?

While regulatory labeling does not typically list specific herbal interactions, it advises patients to inform their healthcare provider about all concurrent medications, including any herbal supplements, due to the potential for unforeseen interactions.

Advertisements

How should Hidrocortisona Klonal be stored and disposed of?

How to Store and Dispose of Hydrocortisone Klonal

This medication must be stored at controlled room temperature, typically between 20 C and 25 C. It is essential to protect the product from freezing and excessive heat or moisture to maintain its stability. Keep the container tightly closed and store the medicine out of the reach of children.

For injectable forms, the reconstituted solution has a limited stability period and must be discarded within hours, even if refrigerated. Unused or expired Hydrocortisone Klonal must be disposed of according to local pharmaceutical waste regulations and should not be thrown into household trash or wastewater. Consult a healthcare provider for specific disposal instructions.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Hidrocortisona Klonal found in:

A-Z Index: